ACCELERATED RECONSTITUTION OF PLATELETS AND ERYTHROCYTES AFTER SYNGENEIC TRANSPLANTATION OF BONE-MARROW CELLS DERIVED FROM THROMBOPOIETIN PRETREATED DONOR MICE

被引:81
作者
FIBBE, WE
HEEMSKERK, DPM
LATERVEER, L
PRUIJT, JFM
FOSTER, D
KAUSHANSKY, K
WILLEMZE, R
机构
[1] ZYMOGENET CORP,SEATTLE,WA
[2] WASHINGTON UNIV,SCH MED,DIV HEMATOL,SEATTLE,WA
关键词
D O I
10.1182/blood.V86.9.3308.bloodjournal8693308
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The recent cloning of the ligand of the c-Mpl hematopoietin receptor has indicated a major role for this cytokine in the development of megakaryocytes. In this study we have applied c-Mpl ligand (thrombopoietin [TPO]) in the setting of syngeneic transplantation in an attempt to accelerate the reconstitution of platelets. Donor mice were treated with 20 kilounits (kU)/d TPO intraperitoneally (ip) for 5 days. This resulted in a 2.5-fold increment in platelet counts from 1,119 x 10(9)/L to 2,582 x 10(9)/L (mean, n = 7). Total numbers of hematopoietic progenitor cells in bone marrow (BM) and spleen, as assessed in a colony-forming unit-granulocyte erythroid monocyte macrophage (CFU-GEMM) colony assay (55.3 v 38.6 x 10(3) CFU/femur; 27.3 v 16.3 x 10(3) CFU/spleen, mean, n = 7) as well as total numbers of burst-forming unit-erythroid (BFU-E) (24.0 v 16.4 x 10(3)/femur; 10.2 v 1.9 x 10(3)/spleen, mean, n = 7), were significantly higher in TPO-treated donors than in saline-treated controls. Female Balb-C mice were lethally (8.5 Gy) irradiated and transplantated with 10(5) BM cells. After transplantation, groups of mice were treated with recombinant murine TPO at a dose of 20 to 30 kU/d ip or subcutaneously (SC) for 5 to 14 days. Using this dose and schedule, TPO did not stimulate the recovery of platelets in comparison with control animals transplanted with equal cell numbers but given vehicle alone. In other experiments, 10(5) BM cells were procured from TPO-treated donor mice and transplanted into lethally irradiated recipient mice. In comparison with animals transplanted with an equal number of BM cells derived from saline-treated controls, recipients of TPO-treated BM cells had significantly faster platelet recovery and higher platelet nadir counts (88 v 30 x 10(9)/L, mean, n = 20). Transplantation of TPO-treated BM cells also resulted in an accelerated recovery of erythrocytes and increased erythrocyte nadir counts (7.2 v 5.0 x 10(12)/L, mean, n = 20), At the day of platelet nadir (day 12 after transplantation) these animals had higher numbers of BFU-Es (770 v 422, mean, n = 5) in the marrow and also had higher reticulocyte counts (44 parts per thousand v 8 parts per thousand, mean, n = 5) in the blood. Therefore, the accelerated recovery of erythrocytes may be a direct effect of TPO on erythropoiesis. Our results indicate that pretreatment of donor animals with TPO before marrow procurement may be an effective alternative method to accelerate the reconstitution of platelets and erythrocytes after lethal irradiation and syngeneic stem cell transplantation. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:3308 / 3313
页数:6
相关论文
共 21 条
  • [1] IDENTIFICATION AND CLONING OF A MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR THAT IS A LIGAND FOR THE CYTOKINE RECEPTOR MPL
    BARTLEY, TD
    BOGENBERGER, J
    HUNT, P
    LI, YS
    LU, HS
    MARTIN, F
    CHANG, MS
    SAMAL, B
    NICHOL, JL
    SWIFT, S
    JOHNSON, MJ
    HSU, RY
    PARKER, VP
    SUGGS, S
    SKRINE, JD
    MEREWETHER, LA
    CLOGSTON, C
    HSU, E
    HOKOM, MM
    HORNKOHL, A
    CHOI, E
    PANGELINAN, M
    SUN, Y
    MAR, V
    MCNINCH, J
    SIMONET, L
    JACOBSEN, F
    XIE, C
    SHUTTER, J
    CHUTE, H
    BASU, R
    SELANDER, L
    TROLLINGER, D
    SIEU, L
    PADILLA, D
    TRAIL, G
    ELLIOTT, G
    IZUMI, R
    COVEY, T
    CROUSE, J
    GARCIA, A
    XU, W
    DELCASTILLO, J
    BIRON, J
    COLE, S
    HU, MCT
    PACIFICI, R
    PONTING, I
    SARIS, C
    WEN, D
    [J]. CELL, 1994, 77 (07) : 1117 - 1124
  • [2] THE MPI RECEPTOR IS EXPRESSED IN THE MEGAKARYOCYTIC LINEAGE FROM LATE PROGENITORS TO PLATELETS
    DEBILI, N
    WENDLING, F
    COSMAN, D
    TITEUX, M
    FLORINDO, C
    DUSANTERFOURT, I
    SCHOOLEY, K
    METHIA, N
    CHARON, M
    NADOR, R
    BETTAIEB, A
    VAINCHENKER, W
    [J]. BLOOD, 1995, 85 (02) : 391 - 401
  • [3] STIMULATION OF MEGAKARYOCYTOPOIESIS AND THROMBOPOIESIS BY THE C-MPL LIGAND
    DESAUVAGE, FJ
    HASS, PE
    SPENCER, SD
    MALLOY, BE
    GURNEY, AL
    SPENCER, SA
    DARBONNE, WC
    HENZEL, WJ
    WONG, SC
    KUANG, WJ
    OLES, KJ
    HULTGREN, B
    SOLBERG, LA
    GOEDDEL, DV
    EATON, DL
    [J]. NATURE, 1994, 369 (6481) : 533 - 538
  • [4] FIBBE WE, 1992, J IMMUNOL, V148, P417
  • [5] GORDON MS, 1992, BLOOD, V80, P302
  • [6] HOFFMAN R, 1989, BLOOD, V74, P1196
  • [7] PROMOTION OF MEGAKARYOCYTE PROGENITOR EXPANSION AND DIFFERENTIATION BY THE C-MPL LIGAND THROMBOPOIETIN
    KAUSHANSKY, K
    LOK, S
    HOLLY, RD
    BROUDY, VC
    LIN, N
    BAILEY, MC
    FORSTROM, JW
    BUDDLE, MM
    OORT, PJ
    HAGEN, FS
    ROTH, GJ
    PAPAYANNOPOULOU, T
    FOSTER, DC
    [J]. NATURE, 1994, 369 (6481) : 568 - 571
  • [8] THROMBOPOIETIN EXPANDS ERYTHROID PROGENITORS, INCREASES RED-CELL PRODUCTION, AND ENHANCES ERYTHROID RECOVERY AFTER MYELOSUPPRESSIVE THERAPY
    KAUSHANSKY, K
    BROUDY, VC
    GROSSMANN, A
    HUMES, J
    LIN, N
    REN, HP
    BAILEY, MC
    PAPAYANNOPOULOU, T
    FORSTROM, JW
    SPRUGEL, KH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) : 1683 - 1687
  • [9] KUTER DJ, 1994, AUG WORKSH MEG PLAT
  • [10] LATERVEER L, 1993, EXP HEMATOL, V21, P1621